NEUREN PHARMACEUTICALS LIMITED |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 19.25 AUD | +3.22% |
|
-0.16% | -22.91% |
| Apr. 24 | Neuren Pharmaceuticals Posts AU$243 Million Cash, Short-Term Investments | MT |
| Apr. 23 | Neuren Pharmaceuticals' Medication Secures Priority Review from Health Canada | MT |
Evolution of the average Target Price on Neuren Pharmaceuticals Limited
Price target over the last 5 years
History of analyst recommendation changes
920ed32ff49dddff918eb8b5a9b79b.feBtHnWcdqdR1bN-0pJaofSsOsgd6DffyguUnPAjhrI.K7NYZhDlPNQYof8wmOAd1Jn2CaVIum6TlWng1ZpQweYRiw9MEO813juG5g~c49e69e620e0e3d8733d42e87f26dddd
Analysts' Consensus
Sell
Buy
Mean consensus
BUY
Number of Analysts
5
Last Close Price
18.65
AUD
Average target price
26.74
AUD
Spread / Average Target
+43.36%
High Price Target
31
AUD
Spread / Highest target
+66.22%
Low Price Target
22.8
AUD
Spread / Lowest Target
+22.25%
Consensus detail
Consensus revision (last 18 months)
Trading Rating
Investor Rating
ESG Refinitiv
D+
EPS Revisions
- Stock Market
- Equities
- NEU Stock
- Consensus Neuren Pharmaceuticals Limited
